価格表

在庫・価格 : 2026年04月06日 21時32分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-TRAIL R1/TNFRSF10A, Mouse-Mono(32A1380)
データシート※最新のデータシートでない場合があります
NB100-56747SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 mg ¥41,000
(未発注)
追加

在庫・価格 : 2026年04月06日 21時32分 現在

Anti-TRAIL R1/TNFRSF10A, Mouse-Mono(32A1380)

  • 商品コード:NB100-56747SS
  • メーカー:NOV
  • 包装:0.025mg
  • 価格: ¥41,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Lin YD et al. CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells. Cancer Res. 2008 Jul;68(13):5335-44
Lin YD et al
2008/01/01
Applications: WB PubMed
2 Tsurushima H et al. Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors. Cancer Gene Ther. 2007 Aug;14(8):706-16
Tsurushima H et al
2007/01/01
Species: Human, Applications: Flow-IC PubMed
3 Allen JE et al. Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes. Mol. Cancer Ther. 2012 Oct;11(10):2087-95
Allen JE et al
2012/01/01
Applications: PubMed
4 Jane EP et al. Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway. Mol. Cancer Ther. 2011 Jan;10(1):198-208
Jane EP et al
2011/01/01
Applications: WB PubMed
5 Le Poole IC et al. Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells. Cancer Immunol. Immunother. 2008 Jun;57(6):789-97
Le Poole IC et al
2008/01/01
Species: Human, Applications: Flow - CS PubMed
6 Krishnamoorthy B et al. Glioma cells deficient in urokinase plaminogen activator receptor expression are susceptible to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis. Clin. Cancer Res. 2001 Dec;7(12):4195-201
Krishnamoorthy B et al
2001/01/01
Applications: PubMed
7 Lu G et al. Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand. J. Immunol. 2002 Feb;168(4):1831-9
Lu G et al
2002/01/01
Applications: PubMed
8 Chen X et al. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Cancer Res. 2003 Mar;63(5):1059-66
Chen X et al
2003/01/01
Applications: PubMed
9 Kroll TM et al. 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. J. Invest. Dermatol. 2005 Apr;124(4):798-806
Kroll TM et al
2005/01/01
Applications: Flow PubMed
10 Sridhar S et al. Differential expression of members of the tumor necrosis factor alpha-related apoptosis-inducing ligand pathway in prostate cancer cells. Cancer Res. 2001 Oct;61(19):7179-83
Sridhar S et al
2001/01/01
Applications: PubMed
11 Shigeno M et al. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Oncogene 2003 Mar;22(11):1653-62
Shigeno M et al
2003/01/01
Applications: PubMed
12 Park S et al. Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins. Mol. Cell. Biochem. 2013 Nov;383(1-2):39-48
Park S et al
2013/01/01
Applications: PubMed
13 Qiu F et al. Annexin V-TRAIL fusion protein is a more sensitive and potent apoptotic inducer for cancer therapy. Sci Rep 2013;3:3565
Qiu F et al
2013/01/01
Species: Human, Applications: WB PubMed
14 Ren YG et al. Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle. Mol. Biol. Cell 2004 Nov;15(11):5064-74
Ren YG et al
2004/01/01
PubMed
15 Bretz JD et al. Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells. Cell Death Differ. 2002 Mar;9(3):274-86
Bretz JD et al
2002/01/01
PubMed
16 Liu X et al. p53 upregulates death receptor 4 expression through an intronic p53 binding site. Cancer Res. 2004 Aug;64(15):5078-83
Liu X et al
2004/01/01
PubMed
17 Guan B et al. Evidence that the human death receptor 4 is regulated by activator protein 1. Oncogene 2002 May;21(20):3121-9
Guan B et al
2002/01/01
PubMed
18 Lee SH et al. E2 of hepatitis C virus inhibits apoptosis. J. Immunol. 2005 Dec;175(12):8226-35
Lee SH et al
2005/01/01
PubMed
  • No.: 1
  • 文献情報:
    Lin YD et al. CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells. Cancer Res. 2008 Jul;68(13):5335-44
    Lin YD et al
    2008/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Tsurushima H et al. Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors. Cancer Gene Ther. 2007 Aug;14(8):706-16
    Tsurushima H et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Flow-IC
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Allen JE et al. Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes. Mol. Cancer Ther. 2012 Oct;11(10):2087-95
    Allen JE et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Jane EP et al. Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway. Mol. Cancer Ther. 2011 Jan;10(1):198-208
    Jane EP et al
    2011/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Le Poole IC et al. Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells. Cancer Immunol. Immunother. 2008 Jun;57(6):789-97
    Le Poole IC et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Flow - CS
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Krishnamoorthy B et al. Glioma cells deficient in urokinase plaminogen activator receptor expression are susceptible to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis. Clin. Cancer Res. 2001 Dec;7(12):4195-201
    Krishnamoorthy B et al
    2001/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Lu G et al. Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand. J. Immunol. 2002 Feb;168(4):1831-9
    Lu G et al
    2002/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Chen X et al. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Cancer Res. 2003 Mar;63(5):1059-66
    Chen X et al
    2003/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Kroll TM et al. 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. J. Invest. Dermatol. 2005 Apr;124(4):798-806
    Kroll TM et al
    2005/01/01
  • 備考:
    Applications: Flow
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Sridhar S et al. Differential expression of members of the tumor necrosis factor alpha-related apoptosis-inducing ligand pathway in prostate cancer cells. Cancer Res. 2001 Oct;61(19):7179-83
    Sridhar S et al
    2001/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Shigeno M et al. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Oncogene 2003 Mar;22(11):1653-62
    Shigeno M et al
    2003/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Park S et al. Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins. Mol. Cell. Biochem. 2013 Nov;383(1-2):39-48
    Park S et al
    2013/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Qiu F et al. Annexin V-TRAIL fusion protein is a more sensitive and potent apoptotic inducer for cancer therapy. Sci Rep 2013;3:3565
    Qiu F et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Ren YG et al. Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle. Mol. Biol. Cell 2004 Nov;15(11):5064-74
    Ren YG et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Bretz JD et al. Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells. Cell Death Differ. 2002 Mar;9(3):274-86
    Bretz JD et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Liu X et al. p53 upregulates death receptor 4 expression through an intronic p53 binding site. Cancer Res. 2004 Aug;64(15):5078-83
    Liu X et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Guan B et al. Evidence that the human death receptor 4 is regulated by activator protein 1. Oncogene 2002 May;21(20):3121-9
    Guan B et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Lee SH et al. E2 of hepatitis C virus inhibits apoptosis. J. Immunol. 2005 Dec;175(12):8226-35
    Lee SH et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed